Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Apply
Toripalimab & Tifcemalimab
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step